End-of-day quote
Hong Kong S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
19.06
USD
|
+0.63%
|
|
-17.31%
|
-40.44%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
---|
Capitalization
1 |
20,770
|
20,770
|
-
|
Enterprise Value (EV)
1 |
34,275
|
17,403
|
17,569
|
P/E ratio
|
112
x
|
36.2
x
|
22.8
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
16.1
x
|
6.57
x
|
4.5
x
|
EV / Revenue
|
16.1
x
|
5.51
x
|
3.81
x
|
EV / EBITDA
|
92
x
|
21.9
x
|
14.1
x
|
EV / FCF
|
-23.5
x
|
-20
x
|
-403
x
|
FCF Yield
|
-4.26%
|
-5%
|
-0.25%
|
Price to Book
|
4.19
x
|
3.54
x
|
3.06
x
|
Nbr of stocks (in thousands)
|
1,178,446
|
1,178,446
|
-
|
Reference price
2 |
17.62
|
17.62
|
17.62
|
Announcement Date
|
3/25/24
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
2,124
|
3,160
|
4,614
|
EBITDA
1 |
-
|
372.5
|
793.3
|
1,249
|
EBIT
1 |
-
|
343.5
|
661.1
|
1,067
|
Operating Margin
|
-
|
16.17%
|
20.92%
|
23.12%
|
Earnings before Tax (EBT)
1 |
-
|
359.6
|
704.9
|
1,125
|
Net income
1 |
155.7
|
283.5
|
575.5
|
918.3
|
Net margin
|
-
|
13.35%
|
18.21%
|
19.9%
|
EPS
2 |
0.1800
|
0.2600
|
0.4873
|
0.7726
|
Free Cash Flow
1 |
-
|
-735
|
-870.7
|
-43.62
|
FCF margin
|
-
|
-40.71%
|
-27.55%
|
-0.95%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
Announcement Date
|
11/6/23
|
3/25/24
|
-
|
-
|
Fiscal Period: December |
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
875.9
|
1,392
|
1,702
|
EBITDA
|
-
|
-
|
-
|
EBIT
1 |
168
|
337.6
|
423.4
|
Operating Margin
|
19.18%
|
24.25%
|
24.88%
|
Earnings before Tax (EBT)
1 |
70
|
-
|
-
|
Net income
1 |
56
|
-
|
-
|
Net margin
|
6.39%
|
-
|
-
|
EPS
2 |
0.0400
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
3,519
|
3,367
|
3,201
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-735
|
-871
|
-43.6
|
ROE (net income / shareholders' equity)
|
-
|
8.35%
|
10.2%
|
14.2%
|
ROA (Net income/ Total Assets)
|
-
|
5.57%
|
9.45%
|
12%
|
Assets
1 |
-
|
4,456
|
6,089
|
7,671
|
Book Value Per Share
2 |
-
|
4.210
|
4.980
|
5.750
|
Cash Flow per Share
2 |
-
|
0.3600
|
0.6000
|
0.7500
|
Capex
1 |
-
|
695
|
1,546
|
918
|
Capex / Sales
|
-
|
38.47%
|
48.92%
|
19.9%
|
Announcement Date
|
11/6/23
|
3/25/24
|
-
|
-
|
Last Close Price
17.62
CNY Average target price
28.8
CNY Spread / Average Target +63.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -40.44% | 2.87B | | +30.38% | 684B | | +26.51% | 568B | | -4.36% | 361B | | +19.30% | 329B | | +3.73% | 284B | | +16.70% | 240B | | +8.78% | 208B | | -7.93% | 200B | | +7.68% | 166B |
Other Pharmaceuticals
|